Article Information
History
- November 5, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- James E. Siegler1,*,
- Elena Badillo Goicoechea1,
- Shadi Yaghi2,
- Rami Z. Morsi1,
- Andrea Arevalo1,
- Matthew M. Smith1,
- Sachin Kothari1,
- Harsh Desai1,
- Neha Sehgal1,
- Rohini Rana1,
- Caroline Kellogg3,
- Aditya Jhaveri1,
- Adam de Havenon4,
- Therese Dunne5,
- Kamil Cameron6,
- Seemant Chaturvedi7,
- Malik Ghannam5,
- Shyam Prabhakaran1,
- Elisheva Coleman1,
- James R. Brorson1,
- Rachel Mehendale1 and
- Tareq Kass-Hout1
- 1Department of Neurology, University of Chicago, Chicago, IL
- 2Department of Neurology, Lifespan Hospital, Providence, RI
- 3University of Chicago, Chicago, IL
- 4Department of Neurology, Yale School of Medicine, New Haven, CT
- 5Department of Neurology, Advocate Lutheran General Hospital, Chicago, IL
- 6Delaware State University, Dover, DE
- 7Department of Neurology, University of Maryland, Baltimore, MD
- 8Department of Neurology, University of Iowa, Iowa City, IA
- ↵*Corresponding Author: James E. Siegler University of Chicago 5841 S. Maryland Ave MC 2030, S243 Chicago, IL 60637 X: @JimSiegler siegler.james{at}gmail.com
Posted November 05, 2024.
Estimated benefit of PCSK9 inhibition following ischemic stroke due to severe intracranial atherosclerosis
